Skip to main content
Premium Trial:

Request an Annual Quote

NIH Advises Researchers To Authenticate Cell Cultures

NEW YORK (GenomeWeb News) – The National Institutes of Health issued a notice last week that it expects researchers working with cultured cells to use authentication procedures in order to avoid misidentified or contaminated cultures that can significantly affect research outcomes.
 
The NIH cautioned that grant applications that fail to employ authentication methods “would not be considered of the highest quality and such manuscripts would not fare well in the journal review process.”
 
The notification is a response to an open letter from Roland Nardone, a professor at the Discovery Center for Cell and Molecular Biology at the Catholic University of America, and by a number of other biologists, to US Department of Health and Human Services Secretary Michael Leavitt, which said that misidentification of cell lines is a serious and potentially growing problem that can have the potential for “dire consequences.”
 
The authors of the letter advised that “all researchers using cell cultures incorporate a specific cell line authentication protocol into their experimental framework” and that authentication be mandatory in order for researchers to receive grants.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.